Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 78.9B | 73.2B | 80.0B | 75.6B |
Cost of revenue | 60.9B | 56.4B | 63.8B | 59.2B |
Gross profit | 18.1B | 16.9B | 16.2B | 16.4B |
Operating expense | ||||
Research & development | 328.2M | 429.7M | 444.4M | 382.1M |
Selling general and admin | 2.4B | -2.9B | 4.5B | -801.2M |
Other operating expenses | 1.8B | 1.6B | 1.5B | 1.5B |
Operating income | 13.7B | 12.2B | 12.5B | 12.9B |
Non operating interest income | ||||
Income | 524.7M | 687.1M | 652.4M | 668.8M |
Expense | 940.5M | 687.8M | 4.2B | -1.8B |
Other income expense | — | — | — | — |
Pretax income | 14.7B | 12.8B | 13.7B | 12.8B |
Tax provision | 2.2B | 3.0B | 2.5B | 1.9B |
Net income | 12.5B | 9.7B | 11.2B | 10.8B |
Basic EPS | 0.4 | — | — | — |
Diluted EPS | 0.4 | — | — | — |
Basic average shares | 26.5B | — | — | — |
Diluted average shares | 27.0B | — | — | — |
EBITDA | 15.2B | 14.1B | 16.8B | 11.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.3B | -2.0B | -1.9B | -2.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |